NNC109-0012

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC109-0012, covering 2017-02-09 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis [Phase 2]